Guanghua Chen

188 Shizi Street
Suzhou, 215006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Roles of inflammatory cytokines in the pathogenesis of hepatitis B virus-related acute-on-chronic liver failure and CAR-T therapy.

Roles of inflammatory cytokines in the pathogenesis of hepatitis B virus-related acute-on-chronic liver failure and CAR-T therapy.

Journal: Virology journal

Published: January 31, 2025

The interleukin-6 connection: Understanding cytomegalovirus reactivation following CAR-T-cell therapy.

The interleukin-6 connection: Understanding cytomegalovirus reactivation following CAR-T-cell therapy.

Journal: British journal of haematology

Published: January 29, 2025

The efficiency of human umbilical cord mesenchymal stem cells as a salvage treatment for steroid-refractory acute graft-versus-host disease.

The efficiency of human umbilical cord mesenchymal stem cells as a salvage treatment for steroid-refractory acute graft-versus-host disease.

Journal: Clinical and experimental medicine

Published: November 20, 2022

Cytopenia after chimeric antigen receptor T cell immunotherapy in relapsed or refractory lymphoma.

Cytopenia after chimeric antigen receptor T cell immunotherapy in relapsed or refractory lymphoma.

Journal: Frontiers in immunology

Published: July 19, 2022

Anti-CD19 and anti-BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem-cell transplantation for high-risk newly diagnosed multiple myeloma.

Anti-CD19 and anti-BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem-cell transplantation for high-risk newly diagnosed multiple myeloma.

Journal: American journal of hematology

Published: September 28, 2021

Quadruple-hit pleomorphic mantle cell lymphoma with MYC, BCL2, BCL6, and CCND1 gene rearrangements.

Quadruple-hit pleomorphic mantle cell lymphoma with MYC, BCL2, BCL6, and CCND1 gene rearrangements.

Journal: British journal of haematology

Published: September 16, 2021

A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma.

A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma.

Journal: Frontiers in oncology

Published: February 05, 2021

CD4-Targeted T Cells Rapidly Induce Remissions in Mice with T Cell Lymphoma.

CD4-Targeted T Cells Rapidly Induce Remissions in Mice with T Cell Lymphoma.

Journal: BioMed research international

Published: December 31, 2020

CAR-T therapy bridging to allogeneic HSCT provides durable molecular remission of Ph+ mixed phenotype acute leukaemia with minimal residual disease.

CAR-T therapy bridging to allogeneic HSCT provides durable molecular remission of Ph+ mixed phenotype acute leukaemia with minimal residual disease.

Journal: British journal of haematology

Published: July 24, 2020

Sequential CD19 and BCMA-specific CAR T-cell treatment elicits sustained remission of relapsed and/or refractory myeloma.

Sequential CD19 and BCMA-specific CAR T-cell treatment elicits sustained remission of relapsed and/or refractory myeloma.

Journal: Cancer medicine

Published: May 01, 2020

Successful treatment of marrow failure after CARTs for myeloma by the infusion of cryopreserved stem cells.

Successful treatment of marrow failure after CARTs for myeloma by the infusion of cryopreserved stem cells.

Journal: American journal of hematology

Published: August 29, 2019

Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells.

Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells.

Journal: Bone marrow transplantation

Published: October 21, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026